Literature DB >> 27427525

The Evolution and Current Utility of Esophageal Stent Placement for the Treatment of Acute Esophageal Perforation.

Argenis Herrera1, Richard K Freeman2.   

Abstract

Esophageal stent placement was used primarily for the treatment of malignant strictures until the development of a new generation of biomaterials allowed the production of easily removable, occlusive stents in 2001. Since then, thoracic surgeons have gained experience using esophageal stents for the treatment of acute esophageal perforation. As part of a hybrid treatment strategy, including surgical drainage of infected spaces, enteral nutrition, and aggressive supportive care, esophageal stent placement has produced results that can exceed those of traditional surgical repair. This review summarizes the evolution of esophageal stent use for acute perforation and provides evidence-based recommendations for the technique.
Copyright © 2016 Elsevier Inc. All rights reserved.

Keywords:  Esophageal perforation; Esophageal stent placement; Hybrid treatment strategy

Mesh:

Year:  2016        PMID: 27427525     DOI: 10.1016/j.thorsurg.2016.04.012

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  4 in total

Review 1.  Thoracic perforations-surgical techniques.

Authors:  Atilla Eroglu; Yener Aydin; Omer Yilmaz
Journal:  Ann Transl Med       Date:  2018-02

Review 2.  Non-iatrogenic esophageal trauma: a narrative review.

Authors:  Dean P Schraufnagel; Mujtaba Mubashir; Daniel P Raymond
Journal:  Mediastinum       Date:  2022-09-25

3.  Transluminal minimally invasive management of esophageal gunshot wound: The Houdini and friends.

Authors:  Austin Rogers; Rob Allman; Fernando Brea; Dean Yamaguchi; Aundrea Oliver; James Speicher; Mark Iannettoni; Carlos Anciano
Journal:  JTCVS Tech       Date:  2022-05-21

4.  Delayed diagnosis of thoracic esophageal rupture due to blunt abdominal trauma without chest trauma: A case report.

Authors:  Jae Jun Kim; Jung Wook Han
Journal:  J Cardiothorac Surg       Date:  2022-09-03       Impact factor: 1.522

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.